Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 999 999.9999 KRW Market Closed
Market Cap: 71.2T KRW
Have any thoughts about
Samsung Biologics Co Ltd?
Write Note

Relative Value

The Relative Value of one Samsung Biologics Co Ltd stock under the Base Case scenario is 795 617.131 KRW. Compared to the current market price of 999 999.9999 KRW, Samsung Biologics Co Ltd is Overvalued by 20%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
795 617.131 KRW
Overvaluation 20%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
71
vs Industry
12
Median 3Y
16.7
Median 5Y
30.2
Industry
4
Forward
16
vs History
71
vs Industry
5
Median 3Y
68.9
Median 5Y
115.3
Industry
31.2
Forward
69.4
vs History
82
vs Industry
12
Median 3Y
44.3
Median 5Y
82.8
Industry
22.3
vs History
vs Industry
0
Median 3Y
-194.2
Median 5Y
-129.7
Industry
32.7
vs History
50
vs Industry
16
Median 3Y
6.4
Median 5Y
6.9
Industry
2.6
vs History
71
vs Industry
12
Median 3Y
16.6
Median 5Y
29.7
Industry
3.9
Forward
16
vs History
68
vs Industry
9
Median 3Y
33.1
Median 5Y
64.6
Industry
8.5
vs History
69
vs Industry
10
Median 3Y
38.8
Median 5Y
68.2
Industry
18.8
Forward
39.2
vs History
66
vs Industry
6
Median 3Y
52.7
Median 5Y
85.7
Industry
24.3
Forward
53.6
vs History
82
vs Industry
12
Median 3Y
43.9
Median 5Y
81.5
Industry
21.8
vs History
39
vs Industry
6
Median 3Y
69.2
Median 5Y
63.3
Industry
28.7
vs History
53
vs Industry
20
Median 3Y
4.4
Median 5Y
4.9
Industry
2.4

Multiples Across Competitors

Competitors Multiples
Samsung Biologics Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Samsung Biologics Co Ltd
KRX:207940
72.2T KRW 16.6 68.6 37.2 53.5
US
PerkinElmer Inc
LSE:0KHE
1.4T USD 498.5 5 334.5 1 683.2 3 586.9
US
Thermo Fisher Scientific Inc
NYSE:TMO
219.2B USD 5.2 35.7 23 32.9
US
Danaher Corp
NYSE:DHR
176.3B USD 8.3 45.3 28.3 42.6
CH
Lonza Group AG
SIX:LONN
41.3B CHF 6.2 72.5 48.6 48.6
US
Agilent Technologies Inc
NYSE:A
43.5B USD 6.7 33.8 25 29.1
US
IQVIA Holdings Inc
NYSE:IQV
37.4B USD 2.4 26.6 14.6 22.1
US
Mettler-Toledo International Inc
NYSE:MTD
28.7B USD 7.6 36.1 25.8 28.7
US
West Pharmaceutical Services Inc
NYSE:WST
25B USD 8.7 50 33.5 42.2
US
Waters Corp
NYSE:WAT
24.6B USD 8.5 39.5 25.1 30.7
US
Illumina Inc
NASDAQ:ILMN
22.5B USD 5.1 -14.2 32 68.4